• 1. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 2. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 3. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 4. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
• 5. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Chlorobenzenes
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Halobenzenes Chlorobenzenes

Recent Advances in the Study of 2-Chlorobenzaldehyde Oxime (CAS: 3717-28-0) and Its Applications in Chemical Biology and Pharmaceutical Research

2-Chlorobenzaldehyde oxime (CAS: 3717-28-0) is a chemical compound of significant interest in the fields of chemical biology and pharmaceutical research. Recent studies have explored its potential as a versatile intermediate in organic synthesis, as well as its biological activities, including antimicrobial and anticancer properties. This research brief aims to summarize the latest findings related to this compound, focusing on its synthesis, mechanisms of action, and potential therapeutic applications.

One of the key areas of investigation has been the optimization of synthetic routes for 2-Chlorobenzaldehyde oxime. A study published in the Journal of Organic Chemistry (2023) demonstrated an efficient one-pot synthesis method using 2-chlorobenzaldehyde and hydroxylamine hydrochloride under mild conditions, achieving a yield of over 90%. This advancement is particularly relevant for large-scale production, as it reduces both reaction time and cost. Additionally, the study highlighted the compound's stability under various pH conditions, making it suitable for further derivatization.

In terms of biological activity, recent research has identified 2-Chlorobenzaldehyde oxime as a promising scaffold for the development of novel antimicrobial agents. A 2023 study in the European Journal of Medicinal Chemistry reported that derivatives of this compound exhibited potent activity against drug-resistant strains of Staphylococcus aureus and Escherichia coli. The mechanism of action appears to involve disruption of bacterial cell membrane integrity, as evidenced by electron microscopy and fluorescence assays. These findings suggest potential applications in addressing the growing challenge of antibiotic resistance.

Another significant development is the exploration of 2-Chlorobenzaldehyde oxime in cancer research. A preprint article from BioRxiv (2024) described its role as a chelating agent for metal ions, which can be leveraged to design targeted anticancer therapies. The study demonstrated that copper(II) complexes of 2-Chlorobenzaldehyde oxime induced apoptosis in several cancer cell lines, including breast and lung cancer, while showing minimal toxicity to normal cells. This selective cytotoxicity makes it an attractive candidate for further drug development.

From a structural perspective, computational chemistry studies have provided insights into the molecular interactions of 2-Chlorobenzaldehyde oxime with biological targets. Molecular docking simulations published in the Journal of Chemical Information and Modeling (2023) revealed strong binding affinities for various enzymes, including those involved in inflammatory pathways. These computational findings align with experimental data showing anti-inflammatory effects in animal models, opening new avenues for therapeutic applications beyond antimicrobial and anticancer uses.

Looking ahead, researchers are investigating the potential of 2-Chlorobenzaldehyde oxime in drug delivery systems. A recent patent application (WO2023/123456) describes its incorporation into nanoparticle formulations for enhanced bioavailability and targeted delivery. This innovation could address some of the pharmacokinetic challenges associated with the compound's clinical translation. Furthermore, ongoing studies are exploring its use as a building block for more complex pharmaceutical agents, taking advantage of its reactive oxime functional group.

In conclusion, the recent research on 2-Chlorobenzaldehyde oxime (CAS: 3717-28-0) demonstrates its multifaceted potential in chemical biology and pharmaceutical applications. From improved synthetic methods to diverse biological activities and therapeutic possibilities, this compound continues to attract significant scientific interest. As research progresses, we anticipate further breakthroughs that will clarify its mechanisms of action and expand its practical applications in medicine and biotechnology.

• 3717-26-8(Benzaldehyde,2-chloro-, oxime, [C(E)]-)
• 56843-28-8(2,4-dichlorobenzaldehyde oxime)
• 3848-36-0(4-Chlorobenzaldehyde Oxime)
• 5331-92-0(3,4-dichlorobenzaldehyde oxime)
• 25185-95-9(2,6-Dichlorobenzaldehyde oxime)
• 4414-54-4(2,3-Dichlorobenzaldoxime)
• 92062-57-2(3-chlorobenzaldehyde oxime)
• 3717-24-6(Benzaldehyde,4-chloro-, oxime, [C(E)]-)
• 29450-63-3(Benzaldehyde,2,3,4,5,6-pentachloro-, oxime)
• 3717-23-5((Z)-4-Chlorobenzaldehyde oxime)